Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 4 48-4, 2003, Pages

  Nørrelund, Helene ^a   Djurhuus, Christian ^a   Jørgensen, Jens Otto Lunde ^a   Nielsen, Søren ^a   Nair, K Sreekumaran ^b   Schmitz, Ole ^a   Christiansen, Jens Sandahl ^a   Møller, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MAYO CLINIC   (United States)

Author keywords

Fasting; Growth hormone; Substrate metabolism

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; LIPID; PALMITIC ACID; PROTEIN; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET RESTRICTION; EXCRETION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; ISOTOPE DILUTION ASSAY; LIPID METABOLISM; LIPID TRANSPORT; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; STEADY STATE; UREA CYCLE;

EID: 0141504382     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00092.2003     Document Type: Article

References (43)

1. Bak JF, Moller N, and Schmitz O. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol Endocrinol Metab 260: E736-E742, 1991.
2. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, and Smith C. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88: 960-966, 1991.
3. Bougneres PF, Artavia LE, Ferre P, Chaussain JL, and Job JC. Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab 61: 1152-1157, 1985.
4. Bratusch-Marrain PR, Smith D, and DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55: 973-982, 1982.
5. Butler P, Kryshak E, and Rizza RA. Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans. Am J Physiol Endocrinol Metab 260: E513-E520, 1991.
6. Cahill GF. Starvation in man. N Engl J Med 282: 668-675, 1970.
7. Copeland KC, Underwood LE, and Van Wyk JJ. Induction of immunoreactive somatomedin-C in human serum by growth hormone: dose response relationships, effect on chromatographic profiles. J Clin Endocrinol Metab 50: 690-697, 1980.
8. Erikkson BM and Persson AB. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography. J Chromatogr B Biomed Appl 228: 143-154, 1982.
9. Felig P, Owen OE, Wahren J, and Cahill GF. Amino acid metabolism during prolonged starvation. J Clin Invest 48: 584-594, 1969.
10. Fineberg SE and Merimee TJ. Acute metabolic effects of human growth hormone. Diabetes 23: 499-504, 1974.
11. Fowelin J, Attvall S, von Schenck H, Smith U, and Lager I. Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 34: 500-506, 1991.
12. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
13. Frystyk J, Dinesen B, and Ørskov H. Non-campetitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul 5: 169-176, 1995.
14. Frystyk J, Skjærbæk C, Dinnesen B, and Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348: 185-191, 1994.
15. Hamadeh MJ and Hoffer LJ. Tracer methods underestimate short-term variations in urea production in humans. Am J Physiol 37: E547-E553, 1998.
16. Harrison J, Hodson AW, Skillen AW, Stappenbeck R, Aigus L, and Alberti KGMM. Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment. J Clin Chem Clin Biochem 26: 141-146, 1988.
17. Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, Samojlik E, and Thorner MO. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 74: 757-765, 1992.
18. Haymond MW, Karl I, Weldon VV, and Pagliari AS. The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab 42: 846-856, 1976.
19. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, and Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81: 968-975, 1988.
20. Jahoor F and Wolfe RR. Reassessment of primed constant-infusion tracer method to measure urea kinetics. Am J Physiol Endocrinol Metab 252: E557-E564, 1987.
21. Jensen MD, Rogers PJ, Ellman MG, and Miles JM. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol Endocrinol Metab 254: E562-E565, 1988.
22. Miles JM, Ellman MG, McClean KL, and Jensen MD. Validation of a new method for determination of free fatty acid turnover. Am J Physiol Endocrinol Metab 252: E431-E438, 1987.
23. Møller N, Butler PC, Antsiferov MA, and Alberti KGMM. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32: 105-110, 1989.
24. Møller N, Jørgensen JO, Alberti KG, Flyvbjerg A, and Schmitz O. Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 70: 1179-1186, 1990.
25. Møller N, Jørgensen JO, Schmitz O, Møller J, Christiansen J, Alberti KG, and Ørskov H. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol Endocrinol Metab 258: E86-E91, 1990.
26. Nielsen S, Møller N, Christiansen JS, and Jørgensen JO. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50: 2301-2308, 2001.
27. Nørrelund H, Møller N, Nair KS, Christiansen JS, and Jørgensen JO. Continuation of growth hormone (gh) substitution during fasting in gh-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab 86: 3120-3129, 2001.
28. Nørrelund H, Nair KS, Jørgensen JO, Christiansen JS, and Møller N. The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50: 96-104, 2001.
29. Ørskov L, Schmitz O, Jørgensen JO, Arnfred J, Abildgaard N, Christiansen JS, Alberti KG, and Ørskov H. Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique. J Clin Endocrinol Metab 68: 276-281, 1989.
30. Ørskov H, Thomsen HG, and Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 219: 193-195, 1968.
31. Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, and Pontiroli AE. Mediation of the hepatic effects of growth hormone by its lipolytic activity. J Clin Endocrinol Metab 84: 1658-1663, 1999.
32. Randle PJ, Garland PB, and Hales CNNEA. The glucose-fatty acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
33. Rathgeb I, Steele R, Winkler B, and Altszuler N. Influence of fasting on changes in glucose metabolism induced by growth hormone injection in the normal dog. Diabetes 19: 487-491, 1970.
34. Rizza RA, Mandarino LJ, and Gerich JE. Effects of growth hormone on insulin action in man. Mechanism of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669, 1982.
35. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, and Wajchenberg BL. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48: 1836-1841, 1999.
36. Segerlantz M, Bramnert M, Manhem P, Laurila E, and Groop LC. Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 86: 5813-5818, 2001.
37. Sherwin RS, Hendler RG, and Felig P. Effect of ketone infusion on amino acid and nitrogen metabolism in man. J Clin Invest 55: 1382-1390, 1975.
38. Sherwin RS, Schulman GA, and Hendler RG. Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man. Diabetologia 24: 155-161, 1983.
39. Sirek A, Vranic M, Sirek OV, Vigas M, and Policova Z. Effect of growth hormone on acute glucagon and insulin release. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E107-E112, 1979.
40. Tai TY and Pek S. Direct stimulation by growth hormone of glucagons and insulin release from isolated rat pancreas. Endocrinology 99: 669-677, 1976.
41. Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, and Beck-Nielsen H. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin dependent diabetes mellitus. J Clin Invest 88: 1282-1290, 1991.
42. Yki-Järvinen H, Puhakainen I, and Koivisto VA. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab 72: 1268-1277, 1991.
43. Zierler KL and Rabinowitz D. Roles of insulin and growth hormone, based on studies of forearm metabolism in man. Medicine 42: 385-395, 1963.